Credit Suisse’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2.05M | Buy |
86,223
+13,448
| +18% | +$320K | ﹤0.01% | 1836 |
|
|
2023
Q4 | $1.57M | Buy |
72,775
+1,635
| +2% | +$35.3K | ﹤0.01% | 2032 |
|
|
2023
Q3 | $1.03M | Sell |
71,140
-11,248
| -14% | -$163K | ﹤0.01% | 2274 |
|
|
2023
Q2 | $1.72M | Buy |
82,388
+26,689
| +48% | +$559K | ﹤0.01% | 2003 |
|
|
2023
Q1 | $1.18M | Buy |
55,699
+1,057
| +2% | +$22.3K | ﹤0.01% | 2215 |
|
|
2022
Q4 | $1.39M | Buy |
54,642
+9,443
| +21% | +$240K | ﹤0.01% | 2098 |
|
|
2022
Q3 | $1.09M | Buy |
45,199
+12,467
| +38% | +$300K | ﹤0.01% | 2256 |
|
|
2022
Q2 | $630K | Buy |
32,732
+3,093
| +10% | +$59.5K | ﹤0.01% | 2681 |
|
|
2022
Q1 | $516K | Sell |
29,639
-965
| -3% | -$16.8K | ﹤0.01% | 2937 |
|
|
2021
Q4 | $670K | Buy |
30,604
+3,993
| +15% | +$87.4K | ﹤0.01% | 2853 |
|
|
2021
Q3 | $508K | Buy |
26,611
+2,666
| +11% | +$50.9K | ﹤0.01% | 2977 |
|
|
2021
Q2 | $411K | Sell |
23,945
-1,948
| -8% | -$33.4K | ﹤0.01% | 3121 |
|
|
2021
Q1 | $578K | Sell |
25,893
-29,623
| -53% | -$661K | ﹤0.01% | 2872 |
|
|
2020
Q4 | $1.24M | Sell |
55,516
-6,059
| -10% | -$135K | ﹤0.01% | 2437 |
|
|
2020
Q3 | $908K | Buy |
61,575
+9,641
| +19% | +$142K | ﹤0.01% | 2337 |
|
|
2020
Q2 | $770K | Buy |
+51,934
| New | +$770K | ﹤0.01% | 2458 |
|